Advanced search
Publication Cover
Experimental Lung Research Volume 18, 1992 - Issue 1
Submit an article Journal homepage
7
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Serum Type III Procollagen N-Terminal Peptide in Coal Miners

Yvonne M. W. Janssen Department of Occupational Medicine, Environmental Health, and Toxicology, University of Limburg, Maastricht, The Netherlands; Department of Genetics, University of Limburg, Maastricht, The Netherlands; Department of Physiology and Biophysics and the Department of Biostatics, University of Vermont, Burlington, Vermont
,
John J. M. Engelen Department of Occupational Medicine, Environmental Health, and Toxicology, University of Limburg, Maastricht, The Netherlands; Department of Genetics, University of Limburg, Maastricht, The Netherlands; Department of Physiology and Biophysics and the Department of Biostatics, University of Vermont, Burlington, Vermont
,
Michael S. Giancola Department of Occupational Medicine, Environmental Health, and Toxicology, University of Limburg, Maastricht, The Netherlands; Department of Genetics, University of Limburg, Maastricht, The Netherlands; Department of Physiology and Biophysics and the Department of Biostatics, University of Vermont, Burlington, Vermont
,
Robert B. Low Department of Occupational Medicine, Environmental Health, and Toxicology, University of Limburg, Maastricht, The Netherlands; Department of Genetics, University of Limburg, Maastricht, The Netherlands; Department of Physiology and Biophysics and the Department of Biostatics, University of Vermont, Burlington, Vermont
,
Pamela Vacek Department of Occupational Medicine, Environmental Health, and Toxicology, University of Limburg, Maastricht, The Netherlands; Department of Genetics, University of Limburg, Maastricht, The Netherlands; Department of Physiology and Biophysics and the Department of Biostatics, University of Vermont, Burlington, Vermont
&
Paul J. A. Borm Department of Occupational Medicine, Environmental Health, and Toxicology, University of Limburg, Maastricht, The Netherlands; Department of Genetics, University of Limburg, Maastricht, The Netherlands; Department of Physiology and Biophysics and the Department of Biostatics, University of Vermont, Burlington, Vermont
Pages 1-8 | Received 15 Jun 1990, Accepted 10 Mar 1991, Published online: 02 Jul 2009

References

  • Davis G S, Calhoun W J. Occupational and environmental causes of interstitial lung disease. Interstitial Lung Disease, M I Schwarz, T E King, Jr. B. C. Becker, Toronto 1988; 78–81
  • Engelen J JM, Borm P JA, van Sprundel M, Leenearts L. Blood antioxidant parameters at different stages of pneumoconiosis in coal workers. Red blood cell glutathione: a potential parameter to detect early effects in the lung. Environ Health Perspect 1990; 84: 165–172
  • Borm P JA, Palmen N, Engelen J JM, Buurman W A. Spontaneous and stimulated release of tumor necrosis factor‐alpha (TNF) from blood monocytes of miners with coal workers' pneumoconiosis. Am Rev Respir Dis 1988; 38: 1589–1594
  • Borm P, Palmen N, Engelen J, Buurman W. Oxidants, antioxidants and monokines in the pathogenesis of coal workers' pneumoconiosis: tumor necrosis factor as a mediator in lung fibrosis. Effects of Mineral Dusts on Cells, B T Mossman, R O Begin. NATO ASI Series, Springer, Berling 1989; Vol H30: 173–180
  • Borm P JA, Meijers J MM, Swaen G MH. Molecular epidemiology of coal worker's pneumoconiosis: application to risk assessment of oxidant and monokine generation by mineral dusts. Exp Lung Res 1990; 16: 57–71
  • Kelley J. Collagen. Lung Cell Biology, D Massaro. Dekker, New York 1989; 821–826
  • Madri J A, Furtmayr H. Collagen polymorphism in the lung: an immunohistochemical study of pulmonary fibrosis. Hum Pathol 1980; 11: 353–366
  • Bateman E D, Turner‐Warwick M, Adelmann‐Grill B C. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax 1981; 36: 645–653
  • Low R B, Cutroneo K R, Davis G S, Giancola B S. Lavage type III procollagen N‐terminal peptides in human pulmonary fibrosis and sarcoidosis. Lab Invest 1983; 48: 755–759
  • Bjermer L, Lundgren R, Hallgren R. Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 1989; 44: 126–131
  • Okazaki I, Maruyama K, Okuno F, Suzuki H, Aoyagi K, Sera Y. Serum type III procollagen peptide in patients with pneumoconiosis. J UOEH 1983; 5: 461–467
  • Cavalleri A, Gobba F, Bacchella L, Luberto F, Ziccardi A. Serum type III procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis. Br J Ind Med 1988; 45: 818–823
  • Okazaki I, Maruyama K, Kobayashi Y, Lilis R, Suzuki Y. Serum type III procollagen peptide: indicator for pulmonary fibrosis, II: application in 80 asbestos insulation workers. Am J Ind Med 1987; 11: 439–466
  • Parmeggiani C. International classification of pneumoconiosis. Encyclopedia Health and Safety, C Parmeggiani. International Labor Organization, Geneva 1983; 1733–1744
  • Risteli L, Risteli J. Radioimmunoassays for monitoring connective tissue metabolism. Rheumatology 1986; 10: 216–245
  • Niemela O. Radioimmunoassays for type III procollagen amino‐terminal peptides in humans. Clin Chem 1985; 31: 1301–1304
  • King T E, Jr, Low R B, Davis G S. Serum and bronchoalveolar lavage N‐terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am Rev Respir Dis, submitted
  • BMDP Statistical Software Manual. University of California Press, Berkeley 1988
  • Conover W J. Practical Nonparametric Statistics. Wiley, New York 1980; 258–260
  • Bjermer L, Thunell M, Hallgren R. Procollagen III peptide in bronchoalveolar lavage fluid: a potential marker of altered collagen synthesis reflecting pulmonary disease in sarcoidosis. Lab Invest 1986; 55: 654–656
  • Anttinen H, Terho E O, Myllyla R, Savolainen E R. Two serum markers of collagen biosynthesis as possible indicators of irreversible pulmonary impairment in farmer's lung. Am Rev Respir Dis 1986; 33: 88–93
  • Cantin A M, Boileau R, Begin R. Increased procollagen III aminoterminal peptide‐related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1988; 137: 572–578
  • Kirk J ME, Bateman E D, Haslam P L, Laurent G J, Turner‐Warwick M. Serum type III procollagen peptide concentration in a cryptogenic fibrosing alveolitis and its clinical relevance. Thorax 1984; 39: 726–732
  • Kuhn C, Boldt J, King T E, Crouch E, Vartio T, McDonald J A. An immunohisto‐chemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989; 140: 1693–1703
  • Murray R F. Tests of so‐called genetic susceptibility. J Occup Med 1986; 28: 1103–1107

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.